Cargando…
The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. AD is characterized by the production and aggregation of beta-amyloid (Aβ) peptides, hyperphosphorylated tau proteins that form neurofibrillary tangles (NFTs), and subsequent neuroinflammation, synaptic dysfunction, autophagy and...
Autores principales: | Zhang, Yuan, Zhao, Yanfang, Ao, Xiang, Yu, Wanpeng, Zhang, Lei, Wang, Yu, Chang, Wenguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283767/ https://www.ncbi.nlm.nih.gov/pubmed/34276336 http://dx.doi.org/10.3389/fnagi.2021.654978 |
Ejemplares similares
-
Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease
por: Zhang, Yuan, et al.
Publicado: (2019) -
Regulation of nuclear factor erythroid-2-related factor 2 as a potential therapeutic target in intracerebral hemorrhage
por: Zhang, Yuan, et al.
Publicado: (2022) -
Exploring the regulatory roles of circular RNAs in Alzheimer’s disease
por: Zhang, Yuan, et al.
Publicado: (2020) -
MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
por: Wei, Wei, et al.
Publicado: (2020) -
Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer
por: Liu, Ying, et al.
Publicado: (2021)